Drug maker Pfizer will pay a record fine of $2.3 billion to settle allegations that it improperly pushed several of its products on patients and physicians alike, according to Reuters. Prosecutors alleged that Pfizer promoted 13 of its drugs for improper uses and doses, including Bextra, a drug meant to treat symptoms associated with arthritis. Pfizer paid $1.3 billion for its false marketing of Bextra as a broader paint treatment drug, as well as a $1 billion civil payment. “We regret certain actions taken in the past, but are proud of the action we’ve taken to strengthen our internal controls, said Amy Schulman, Pfizer’s general counsel.
Pfizer to Pay Record $2.3B Settlement
Pfizer will pay a record fine to settle allegations that it improperly marketed its drugs.
September 3, 2009